Delivery Order SPE2DB22D3501-SPE2DB25FVN24
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vial (30 ml), a pharmaceutical product, at a firm fixed price of $1,704.90. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Gadavist 10 mmol/10 ml vials. The contract has a firm fixed price of $2,194.40 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.10, is for the delivery of Gadavist, a medication used in magnetic resonance imaging (MRI) procedures. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gadavist, a medical imaging agent, with a ceiling value of $1,201.52 and a period of performance through March 14, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,828.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 mL vial of a 10 mmol/mL solution, with a performance period ending on May 6, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gadavist, a pharmaceutical product used for medical imaging, with a ceiling value of $2,051.44 and a period of performance through April 29, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $22,522.21 and an ultimate completion date of September 4, 2024. It is a firm fixed price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Gadavist product to support the medical needs of military treatment facilities and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The firm fixed price contract has a potential value of $6,826.23 and a completion date of January 24, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals,...
This federal contract award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,165.20 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award date is April 1, 2024, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery...